Small molecules,
Big insights™
Metabolomics provides unique, real-time fingerprints of biological systems to reveal novel discoveries and realize the promise of precision medicine.
Services
Advancing Life Science Research & Improving Health
Our untargeted metabolomics technology provides a high-fidelity, reproducible analysis of the current state of a biological system using relative quantitation.
Our targeted panels and assays cover more than 1,000 metabolites and lipids across a wide range of biochemical classes, metabolic pathways, and physiological processes, and they can be customized to best fit any application.
The Complex Lipids Panel is the only available panel providing both quantitative compositional analysis and complete speciation data for unparalleled insight into the lipidome.
This panel provides targeted quantitation of nine short chain fatty acids in either feces or plasma samples. It is available as a Research Use Only (RUO) or Good Clinical Practice (GCP) panel and has applications in gut health, neuroscience, and COVID research.
The Diabetes Research Markers Targeted Panel offers absolute quantitation of 22 metabolites in a single blood sample, allowing you to quantify the levels of key analytes recognized as bioactive promoters and detractors for healthy glucose metabolism.
Explore our full range of products
Advance your Research with Metabolomics
Metabolomics applies to a wide range of research, from soil health to food nutrition and preclinical research to clinical trials. Whether you’re searching for trends in a group or refining an individual’s treatment, metabolomics can help you find answers to important questions.
A Trusted Partner for 20+ Years
A Trusted Partner for 20+ Years
With over 1,300 clients, and 10,000 projects resulting in 3,000 publications, Metabolon has been a trusted partner of researchers for over two decades.
Featured Solution
Diabetes is a serious metabolic condition affecting more than 37 million Americans and 537 million adults worldwide according to the International Diabetes Federation. However, despite being a worldwide epidemic, much remains unknown about individual risk factors for diabetes development, and research is currently being done to identify new and effective treatments for diabetes at all stages.
Diabetes is a serious metabolic condition affecting more than 37 million Americans and 537 million adults worldwide according to the International Diabetes Federation. However, despite being a worldwide epidemic, much remains unknown about individual risk factors for diabetes development, and research is currently being done to identify new and effective treatments for diabetes at all stages.
Latest Events
Careers
We strive to be a workplace where people feel valued and recognized. Through our collective commitment to patients and our customers, we bring our values to life.
Strategic Partnerships
We partner with numerous clinical, biopharma, and population health organizations to build the world’s largest metabolomics database.
Our Company
As the global leader in metabolomics, Metabolon’s mission is to deliver biochemical data and insights that expand and accelerate the impact of life sciences research in all its applications.
Contact Us
Ask questions about how metabolomics can advance your research, request information on sample types and handling procedures, or get a quote for services.
